5-Day brain zapping trial aims to lift severe depression
NCT ID NCT06895863
First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times
Summary
This trial tests a new, accelerated form of brain stimulation for people with severe depression that hasn't improved with medication. Over five days, 78 participants will receive 25 sessions of magnetic stimulation, either targeting a standard brain area or a new one, or a sham (fake) treatment. The goal is to see if this fast, personalized approach can safely and quickly ease depression symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial magnetic stimulation (TMS) using intermittent theta burst stimulation (iTBS)
- What this could lead to
- If it works, this could offer a fast, non-invasive treatment option for people with severe depression that hasn't responded to medication.
- What could go wrong
- This is a relatively small, early-stage trial testing two different brain targets. It's not yet proven to work, and the effects may be modest or not last long.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 78 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 95 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Age range between 18 and 95 years * In- or outpatients with a moderate to severe single episode or periodic MDD according to ICD-10, verified by a M.I.N.I. interview. * Major Depression Inventory (self-rapport) score higher than 25. * Lacking or insufficient effect of at least two drug trials from two distinct classes, e.g., SSRI, SNRI, TCA, or MAO-inhibitors, used in the current episode, with adequate dose and duration as judged by the investigator. * Duration of the current episode must be longer than 2 months but shorter than 4 years, as judged by the investigator. Exclusion criteria: * History of neurologic disease affecting the brain, including dementia and epilepsy * Schizophrenia or any other psychotic disorder except for psychotic depression * Head trauma causing more than 5 minutes loss of consciousness * Suicidal or psychotic symptoms making the transport of participants hazardous * Any form of compulsory admission or treatment within the past three months * Treatment with ECT in the current depressive episode * Non-responders to TBS treatment within the current episode * Current harmful use or dependency of substances according to ICD-10 and interfering with outcome evaluation as judged by investigator's discretion. * High risk of non-adherence as judged by investigators discretion * Medical and psychiatric conditions interfering with study outcome and safety as judged by investigator's discretion. * Female participants of childbearing age must not be pregnant or breast feeding, and they must use contraception during the trial. * One of the prime contra-indications for MRI, including severe claustrophobia (see Appendix 08.05) * One of the prime contra-indications for TMS and persons with electrically, magnetically, or mechanically activated implants or with metal or magnetic pieces in their head (see Appendix 08.04) * Patients who do not wish to be informed about MRI or EEG findings, which may have clinical relevance.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Treatment-resistant depression are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre of Neuropsychiatric Depression Research
RECRUITINGGlostrup Municipality, 2600, Denmark
-
Danish Research Centre for Magnetic Resonance
NOT_YET_RECRUITINGHvidovre, 2650, Denmark
-
Mental Health Center North Zealand
NOT_YET_RECRUITINGHilleroed, 3400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nasal spray aims to lift depression that antidepressants miss
- Can a computer model outsmart depression in older adults?
- Can an anesthetic lift severe depression?
- Can pairing ketamine with talk therapy beat depression alone?
- Can a psychedelic drug lift depression that won't budge?
- Can a 6,000-Person study unlock personalized depression care for asians?